Condition: Rhumatoid Arthisis · Sponsor: Tanta University
This study aims to evaluate the possible efficacy and safety of nicorandil as anti-inflammatory in managing patients with active rheumatoid arthritis.
This description comes directly from the study's public registry record.
Karim Abu Elfath Hussein · +201141332986 · Kareem_hussein@pharm.tanta.edu.eg
Always discuss trial participation with your own doctor first.
| Tanta university | Tanta, Gharbia Governorate, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07516769